Alurion Resources has closed its IPO at the maximum subscription of A$50 million, setting the stage for an expanded development program at its Amargosa Bauxite-Gallium Project. Brazilian Rare Earths retains a strategic 16% stake as Alurion prepares for ASX listing.
- A$50 million raised at A$1.05 per share
- Implied equity valuation of approximately A$256 million
- BRE retains 16% stake post-IPO
- Funds allocated for expanded two-year development program
- ASX listing expected by 30 July 2026 under code 'ALU'
IPO Hits Maximum Subscription, Signaling Strong Market Appetite
Alurion Resources has successfully raised A$50 million in its initial public offering, hitting the maximum subscription limit with demand exceeding available shares. The IPO priced new shares at A$1.05 each, resulting in an implied undiluted equity value of around A$256 million based on the 243.7 million shares on issue post-IPO. This robust capital raising underscores investor confidence in the company’s strategy and the value of its Amargosa Bauxite-Gallium Project.
Significantly, Alurion’s directors and management demonstrated their commitment by subscribing for over A$4.5 million worth of shares, aligning their interests with incoming investors. Brazilian Rare Earths Limited (ASX:BRE), the parent company from which Alurion was demerged, retains a strategic 16% stake valued at approximately A$41 million at the offer price, maintaining a meaningful exposure to the project’s future.
Capital Raise Enables Expanded Two-Year Development Program
The A$50 million capital injection provides Alurion with a strong balance sheet to progress the Amargosa Project through an accelerated and expanded two-year development program. Approximately A$35 million of the proceeds will be directed towards critical project activities including land procurement, environmental and community initiatives, permitting, exploration, and equipment acquisition.
This funding is designed to support a dedicated leadership team and independent governance structure, allowing for focused capital allocation as Alurion advances its bauxite and gallium resource. The project itself hosts a substantial JORC resource and has attracted strong shareholder backing, with 99.94% of votes cast in favour of the demerger at a recent BRE general meeting.
ASX Listing Imminent with Strategic Implications for BRE
Alurion is on track for admission to the ASX Official List by 30 July 2026, with normal trading expected to commence on 3 August under the ticker 'ALU', subject to regulatory approvals. The IPO and demerger structure preserves direct participation for eligible BRE shareholders through an in-specie distribution, while allowing BRE to sharpen its focus on its core rare earth and critical minerals assets.
BRE’s managing director Bernardo da Veiga highlighted that the successful IPO and shareholder endorsement position both companies to concentrate on their respective growth opportunities. For BRE, the next major catalyst will be the Monte Alto Scoping Study due in August 2026, which will provide further clarity on its rare earth projects.
Bottom Line?
Alurion’s fully subscribed IPO equips it to accelerate Amargosa’s development, while BRE refines its rare earth focus ahead of upcoming catalysts.
Questions in the middle?
- How will Alurion’s expanded development program impact project timelines and milestones?
- What strategic moves will BRE pursue with its renewed focus on rare earths following the demerger?
- How might market conditions and commodity prices influence Alurion’s capital allocation and project execution?